Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AROA BIOSURGERY LIMITED Director's Dealing 2024

Aug 22, 2024

64426_rns_2024-08-22_4538dda2-f700-47d6-9f9c-b75389696717.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Darla Hutton
Date of last notice 22 March 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. N/A
Date of change 22 August 2024
No. of securities held prior to change Nil
Class Fully Paid Ordinary Shares
Number acquired 140,110 Fully Paid Ordinary Shares
Number disposed -
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation $40,000 NZD
No. of securities held after change 140,110 Fully Paid Ordinary Shares
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Issued on 22 August 2024 pursuant to Example: on-market trade, off-market trade, exercise of options, shareholder approval received at the Annual issue of securities under dividend reinvestment plan, participation in buy-back General Meeting held on 23 July 2024.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract -
Nature of interest -
Name of registered holder(if issued securities) -
Date of change -
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which the interesthas changed -
Interest acquired -
Interest disposed -
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation -
Interest after change -

Part 3 –[+] Closed period

Were the interests in the securities orcontracts detailed above traded during a+closedperiodwherepriorwrittenclearance was required? No
If so, was prior written clearance providedto allow the trade to proceed during thisperiod? N/A
If prior written clearance was provided, onwhat date was this provided? N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011